Molecular formula:C15H28N4O4
Molecular weight:328.41
Application:It is special drugs use for HxNx virus.
Peramivir is an experimental antiviral drug developed by BioCryst Pharmaceuticals for the treatment of influenza. It has been authorized for the emergency use of treatment of certain hospitalized patients with known or suspected 2009 H1N1 influenza.
Peramivir is a neuraminidase inhibitor, acting as a transition-state analogue inhibitor of influenza neuraminidase and thereby preventing new viruses from emerging from infected cells.
The development of peramivir is supported by the US Department of Health and Human Services as part of the US government's effort to prepare against the threat of an influenza pandemic.
Peramivir is already available in Japan as RAPIACTA (R) and also available in South Korea as PERAMIFLU. Peramivir is currently the only intravenous option for treating swine flu. The drug is in Phase III studies in US.

Please at any time if you are interested in Peramivir.
If you want to know about Peramivir price , please call our Customer Services Hotline +86 592 5365887 or send the email to .

 After send online enquiry, we will reply you as soon as possible, if not get any response on time please contact us by Tel or Email.
Tel: +86 592 5365887
WhatsApp: +86 189 6515 7632

Leave a Message

We will contact you within 24 hours.

 For more information of this product, please send the email to
You may also be intersted in these products.